Atlas Trials

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Clinical trial NCT06562894 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06562894
Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Alopecia Areata
Start date
2025-05-26
Primary completion
2027-05-31
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.